Could an executive order help lower Medicare brand drug prices?
Our Annual Drug Trend Report looks at Medicare brand and generic drug trends
Breaking news of the White House’s consideration of a sweeping executive order that could cut prices on brand-name prescription drugs sold to Medicare and other government programs continues to top this week’s healthcare headlines.
According to Reuters, the order would be “much broader than the Trump Administration's previously disclosed proposal to lower prices on physician administered, or Part B, drugs by tying prices to lower costs in other countries. The administration is now looking at ways to use this or a similar method to lower prices in Medicare's much larger Part D.”
The order reportedly could come within weeks, and it could cover the military healthcare plan as well as the Department of Veterans Affairs, according to White House insider sources at Reuters.
What did Medicare look like in 2018?